A list of letters sent to healthcare professionals in January 2009, to inform of new safety information and advice.
|
Date issued
|
Product
|
Safety information
|
| 16 January 2009 |
Efavirenz: SUSTIVA and STOCRIN (339Kb) |
SUSTIVA efavirenz 100 mg hard capsule formulation will be discontinued. The following SUSTIVA formulations remain available: 50 mg and 200 mg hard capsules; 600 mg film-coated tablets; 30 mg/mL oral solution
In addition, STOCRIN efavirenz 200 mg film-coated tablets may be available on request from January 2009 for individual patients who meet specific criteria
|
| Week commencing 5 January 2009 |
Temsirolimus: Torisel (66Kb) |
Hypersensitivity/infusion reactions (including some life-threatening and rare fatal reactions) have been associated with the administration of temsirolimus (Torisel)
See also Drug Safety Update January 2009, p3
|